139 related articles for article (PubMed ID: 3346909)
1. Interferon-induced changes in pharmacokinetics and tumor uptake of 111In-labeled antimelanoma antibody 96.5 in melanoma patients.
Rosenblum MG; Lamki LM; Murray JL; Carlo DJ; Gutterman JU
J Natl Cancer Inst; 1988 Apr; 80(3):160-5. PubMed ID: 3346909
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
Rosenblum MG; Murray JL; Haynie TP; Glenn HJ; Jahns MF; Benjamin RS; Frincke JM; Carlo DJ; Hersh EM
Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
[TBL] [Abstract][Full Text] [Related]
3. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
[TBL] [Abstract][Full Text] [Related]
4. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
5. Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies.
Rosenblum MG; Murray JL; Lamki L; David G; Carlo D
Cancer Chemother Pharmacol; 1987; 20(1):41-7. PubMed ID: 3621452
[TBL] [Abstract][Full Text] [Related]
6. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
Murray JL; Rosenblum MG; Lamki L; Haynie TP; Glenn HJ; Plager CE; Unger MW; Carlo DJ; Hersh EM
NCI Monogr; 1987; (3):3-9. PubMed ID: 3821916
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
Murray JL; Rosenblum MG; Sobol RE; Bartholomew RM; Plager CE; Haynie TP; Jahns MF; Glenn HJ; Lamki L; Benjamin RS
Cancer Res; 1985 May; 45(5):2376-81. PubMed ID: 3986779
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody.
Taylor A; Milton W; Eyre HP; Christian P; Wu F; Hagan P; Alazraki N; Datz FL; Unger M
J Nucl Med; 1988 Mar; 29(3):329-37. PubMed ID: 3346743
[TBL] [Abstract][Full Text] [Related]
10. Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody.
Carrasquillo JA; Abrams PG; Schroff RW; Reynolds JC; Woodhouse CS; Morgan AC; Keenan AM; Foon KA; Perentesis P; Marshall S
J Nucl Med; 1988 Jan; 29(1):39-47. PubMed ID: 3335926
[TBL] [Abstract][Full Text] [Related]
11. Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.
Scott AM; Lee FT; Hopkins W; Cebon JS; Wheatley JM; Liu Z; Smyth FE; Murone C; Sturrock S; MacGregor D; Hanai N; Inoue K; Yamasaki M; Brechbiel MW; Davis ID; Murphy R; Hannah A; Lim-Joon M; Chan T; Chong G; Ritter G; Hoffman EW; Burgess AW; Old LJ
J Clin Oncol; 2001 Oct; 19(19):3976-87. PubMed ID: 11579119
[TBL] [Abstract][Full Text] [Related]
12. Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans.
Eger RR; Covell DG; Carrasquillo JA; Abrams PG; Foon KA; Reynolds JC; Schroff RW; Morgan AC; Larson SM; Weinstein JN
Cancer Res; 1987 Jun; 47(12):3328-36. PubMed ID: 3581071
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic mice.
Chan SM; Hoffer PB; Maric N; Zoghbi SS; Kirkwood JM; Ernstoff MS; Duray PH; Gerich B
J Nucl Med; 1987 Sep; 28(9):1441-6. PubMed ID: 3476691
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
Larson SM
Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of human fibroblast interferon on the growth of human melanoma cells implanted in nude mice.
Ida N; Uenishi N; Kajita A; Satoh Y
Gan; 1982 Dec; 73(6):952-60. PubMed ID: 7160584
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, tissue distribution, and cell localization of [35S]methionine-labeled recombinant human and murine alpha interferons in mice.
Johns TG; Kerry JA; Veitch BA; Mackay IR; Tutton PJ; Tymms MJ; Cheetham BF; Hertzog PJ; Linnane AW
Cancer Res; 1990 Aug; 50(15):4718-23. PubMed ID: 2369745
[TBL] [Abstract][Full Text] [Related]
17. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
18. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
Murray JL; Zukiwski AA; Mujoo K; Rosenblum MG
J Biol Response Mod; 1990 Dec; 9(6):556-63. PubMed ID: 2074442
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
20. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018).
Kirkwood JM; Neumann RD; Zoghbi SS; Ernstoff MS; Cornelius EA; Shaw C; Ziyadeh T; Fine JA; Unger MW
J Clin Oncol; 1987 Aug; 5(8):1247-55. PubMed ID: 3625247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
